642 related articles for article (PubMed ID: 35837484)
1. Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.
Sun Y; Xia X; Basnet D; Zheng JC; Huang J; Liu J
Front Aging Neurosci; 2022; 14():904152. PubMed ID: 35837484
[TBL] [Abstract][Full Text] [Related]
2. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
Wang Y; Lv MN; Zhao WJ
Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
[TBL] [Abstract][Full Text] [Related]
3. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics.
Li Z; Zhang Y; Ji M; Wu C; Zhang Y; Ji S
Biomed Pharmacother; 2024 Jul; 176():116777. PubMed ID: 38795640
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
Xiang Y; Song X; Long D
Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
[TBL] [Abstract][Full Text] [Related]
5. The role of ferroptosis in neurodegenerative diseases.
Xu Y; Zhao J; Zhao Y; Zhou L; Qiao H; Xu Q; Liu Y
Mol Biol Rep; 2023 Feb; 50(2):1655-1661. PubMed ID: 36385663
[TBL] [Abstract][Full Text] [Related]
6. Substance abuse and neurodegenerative diseases: focus on ferroptosis.
Guo C; Chen L; Wang Y
Arch Toxicol; 2023 Jun; 97(6):1519-1528. PubMed ID: 37100932
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes.
Wang Y; Wu S; Li Q; Sun H; Wang H
Adv Sci (Weinh); 2023 Aug; 10(24):e2300325. PubMed ID: 37341302
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects.
Zhang JB; Jia X; Cao Q; Chen YT; Tong J; Lu GD; Li DJ; Han T; Zhuang CL; Wang P
ACS Chem Neurosci; 2023 Sep; 14(17):2995-3012. PubMed ID: 37579022
[TBL] [Abstract][Full Text] [Related]
9. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.
Cerasuolo M; Di Meo I; Auriemma MC; Trojsi F; Maiorino MI; Cirillo M; Esposito F; Polito R; Colangelo AM; Paolisso G; Papa M; Rizzo MR
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298586
[TBL] [Abstract][Full Text] [Related]
10. Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology.
Wang Y; Tang B; Zhu J; Yu J; Hui J; Xia S; Ji J
Int J Biol Sci; 2022; 18(10):4260-4274. PubMed ID: 35844784
[TBL] [Abstract][Full Text] [Related]
11. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Roles of Ferroptosis in Huntington's Disease.
Mi Y; Gao X; Xu H; Cui Y; Zhang Y; Gou X
Neuromolecular Med; 2019 Jun; 21(2):110-119. PubMed ID: 30600476
[TBL] [Abstract][Full Text] [Related]
14. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
Viktorinova A; Durfinova M
Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
[TBL] [Abstract][Full Text] [Related]
15. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products.
Yang K; Zeng L; Zeng J; Deng Y; Wang S; Xu H; He Q; Yuan M; Luo Y; Ge A; Ge J
Ageing Res Rev; 2023 Nov; 91():102063. PubMed ID: 37673132
[TBL] [Abstract][Full Text] [Related]
16. Insight into the potential role of ferroptosis in neurodegenerative diseases.
Ji Y; Zheng K; Li S; Ren C; Shen Y; Tian L; Zhu H; Zhou Z; Jiang Y
Front Cell Neurosci; 2022; 16():1005182. PubMed ID: 36385946
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases.
Johnson J; Mercado-Ayon E; Mercado-Ayon Y; Dong YN; Halawani S; Ngaba L; Lynch DR
Arch Biochem Biophys; 2021 May; 702():108698. PubMed ID: 33259796
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.
Zhou J; Jin Y; Lei Y; Liu T; Wan Z; Meng H; Wang H
Neurodegener Dis; 2020; 20(1):20-34. PubMed ID: 32814328
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease.
Lane DJR; Metselaar B; Greenough M; Bush AI; Ayton SJ
Essays Biochem; 2021 Dec; 65(7):925-940. PubMed ID: 34623415
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
